Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Treatment of Latent Tuberculosis Infection (Preventive Therapy)

This fact sheet, available online or via fax only, discusses who should receive treatment, regimen options for HIV-infected persons as well as those not infected, and monitoring.

Author:

CDC NCHHSTP Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention, Division of Tuberculosis Elimination

Topic:

HIV Co-infection, Treatment - Latent TB infection (Inactive TB)

Country of Origin:

United States

View Webpage

Related Materials

Latent Tuberculosis Infection Treatment Regimens

This info sheet summarizes the updated 2020 LTBI treatment guidelines that apply to persons with LTBI who live in the United States

Information Sheet

Treatment of Latent Tuberculosis Infection: Maximizing Adherence

This fact sheet provides strategies for health care providers to use to maximize adherence by their patients for the treatment of latent tuberculosis infection (LTBI).

Fact Sheet

New Treatment Regimen for Latent Tuberculosis Infection

The Communications, Education, and Behavioral Studies Branch (CEBSB) in the Division of Tuberculosis Elimination (DTBE) at CDC developed a video podcast on the 12-dose treatment regimen for latent tuberculosis infection. The video podcast features Dr. Kenneth Castro and is available in English and Spanish. Additional 12-dose regimen communication products are available on the CDC TB Web site (http://www.cdc.gov/tb/).

Webpage

Global resources for the prevention,
management, and elimination of TB.